785 related articles for article (PubMed ID: 33017027)
1. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
[TBL] [Abstract][Full Text] [Related]
2. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel prognostic signature based on single-cell combined bulk RNA analysis in breast cancer.
Xiao Y; Hu G; Xie N; Yin L; Pan Y; Liu C; Lou S; Zhu C
J Gene Med; 2024 Feb; 26(2):e3673. PubMed ID: 38404059
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer.
He M; Hu C; Deng J; Ji H; Tian W
World J Surg Oncol; 2021 Oct; 19(1):294. PubMed ID: 34600547
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel ubiquitination related gene signature for patients with breast cancer.
Zheng Y; Lu W; Chen B; Zhao K
Medicine (Baltimore); 2022 Sep; 101(37):e30598. PubMed ID: 36123926
[TBL] [Abstract][Full Text] [Related]
7. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
8. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.
Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M
Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321
[No Abstract] [Full Text] [Related]
9. A 17-gene expression-based prognostic signature associated with the prognosis of patients with breast cancer: A STROBE-compliant study.
Qian JX; Yu M; Sun Z; Jiang AM; Long B
Medicine (Baltimore); 2020 Apr; 99(15):e19255. PubMed ID: 32282693
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of prognosis-associated DNA repair gene signatures in colorectal cancer.
Song D; Zhang D; Chen S; Wu J; Hao Q; Zhao L; Ren H; Du N
Sci Rep; 2022 Apr; 12(1):6946. PubMed ID: 35484177
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA-based signatures to improve prognostic prediction of breast cancer.
Zhang Y; Wang Y; Tian G; Jiang T
Medicine (Baltimore); 2020 Oct; 99(40):e22203. PubMed ID: 33019395
[TBL] [Abstract][Full Text] [Related]
12. Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancer.
Ren X; Cui H; Wu J; Zhou R; Wang N; Liu D; Xie X; Zhang H; Liu D; Ma X; Dang C; Kang H; Lin S
Cancer Med; 2022 Oct; 11(20):3886-3901. PubMed ID: 35441810
[TBL] [Abstract][Full Text] [Related]
13. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
[TBL] [Abstract][Full Text] [Related]
14. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
Front Oncol; 2022; 12():915662. PubMed ID: 36033441
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.
Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X
J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839
[TBL] [Abstract][Full Text] [Related]
16. A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.
Xue Y; Li J; Lu X
Technol Cancer Res Treat; 2020; 19():1533033820935860. PubMed ID: 32588760
[TBL] [Abstract][Full Text] [Related]
17. A seven-DNA methylation signature as a novel prognostic biomarker in breast cancer.
Tao C; Luo R; Song J; Zhang W; Ran L
J Cell Biochem; 2020 Mar; 121(3):2385-2393. PubMed ID: 31646666
[TBL] [Abstract][Full Text] [Related]
18. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of autophagy-related prognostic genes in breast cancer.
Lai J; Chen B; Mok H; Zhang G; Ren C; Liao N
J Cell Mol Med; 2020 Aug; 24(16):9145-9153. PubMed ID: 32618109
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic biomarkers of breast cancer based on the immune-related gene module.
Wang R; Zeng H; Xiao X; Zheng J; Ke N; Xie W; Lin Q; Zhang H
Autoimmunity; 2023 Dec; 56(1):2244695. PubMed ID: 37584152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
